Table 2.
Descriptive statistics for patient-completed measures
Sample/measure | Characteristic | ||
---|---|---|---|
Mean | ±SD | Range | |
UUI/OAB (n = 53) | |||
PGI-Sa | 3.0 | ±1.0 | 1–5 |
OAB-q SF: symptom botherb | 46.1 | ±24.3 | 0.0–100.0 |
OAB-q SF: HRQoLb | 66.2 | ±21.8 | 9.2–100.0 |
ABSSTc | 3.3 | ±2.2 | 0.0–8.0 |
Non-UUI/OAB (n = 47) | |||
PGI-Sa | 1.2 | ±0.6 | 1–4 |
OAB-q SF: symptom botherb | 11.2 | ±16.3 | 0.0–70.0 |
OAB-q SF: HRQoLb | 95.6 | ±10.9 | 43.1–100.0 |
ABSSTc | 0.6 | ±1.0 | 0.0–4.0 |
ABSST Actionable Bladder Symptoms Screening Tool, HRQoL health-related quality of life, OAB-q SF Overactive Bladder Questionnaire Short Form, PGI-S Patient Global Impression of Severity, UUI urinary urgency incontinence
aScores have a possible range of 1–5. Higher scores indicate greater symptom severity
bScores have a possible range of 0–100. Higher scores on the symptom bother scale indicate greater symptom severity/bother or impact, while higher scores on the HRQoL subscale indicate better HRQoL or less impact
cScores have a possible range of 0–8. Higher scores indicate greater symptom severity or impact